1011 
Dr Farah Chaudhry, Consultant in Sexual and Reproductive Health for Leeds Sexual Health, West Yorkshire, describes how point-of-care ultrasound (POCUS) allows her to give informed and clear assurances to women using long-acting contraception.
I spent 10 years as a GP in Leeds, developing a special interest and expertise in women’s health, in particular complex contraception. After that, I decided to pursue the specialty of sexual and reproductive health full time. I managed the complex contraception clinics in Kirklees and Bradford for Locala Community Partnerships – an independent social enterprise providing a range of NHS services in the communities of West Yorkshire – and am now carrying out a similar role for Leeds Sexual Health.
Complex contraception services are for women who experience difficulties with particular methods of contraception, mostly because of persistent bleeding, or for those who are already using long-acting methods, such as implants or intrauterine contraceptives (IUCs), but require specialist treatment or advice. Referrals occur when community health practitioners have concerns about the location, and therefore efficacy, of a previously fitted device, for example, because the implant under the skin in the upper arm is no longer palpable. Using ultrasound, I’m able to locate the implant and, depending on its position, proceed to removal. Similarly, IUC threads can also migrate; when in situ, threads attached to the lower end of the IUC traverse the cervical canal and exit the os to allow for removal. These may not be visible to the clinician on examination and therefore ultrasound-guided intervention is required to assess that the IUC is still in a satisfactory position in the uterus to provide contraceptive cover and has not been expelled or perforated. If necessary, the IUC can be safely removed under ultrasound guidance and a new coil inserted.
Using POCUS in my contraception clinics allows me to give women definitive information. It also lets me provide guided intervention to resolve any complications, often at a time of significant concern and anxiety. Ultrasound is an invaluable clinical tool in my practice; it offers peace of mind for the specialist and, more importantly, for the women needing our support.
SonoSite is a registered trademarks of FUJIFILM SonoSite, Inc. in various jurisdictions. FUJIFILM is a trademark and registered trademark of FUJIFILM Corporation in various jurisdictions. All other trademarks are the property of their respective owners. Copyright (c) 2018 FUJIFILM SonoSite, Inc. All rights reserved. Subject to change.
Medical scope of practice can vary by state, country and/or local jurisdiction.
About FUJIFILM SonoSite, Inc.
SonoSite helped pioneer the concept of portable, point-of-care ultrasound, and it continues to be a world-leading manufacturer and innovator of bedside ultrasound systems as well as an industry leader in ultra high-frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by 26 subsidiaries and a global distribution network in over 100 countries. SonoSite’s portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, go to: www.sonosite.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous innovation and leading-edge products to a broad spectrum of industries, including electronic imaging, digital printing equipment, medical systems, life sciences, graphic arts, flat panel display materials, and office products, based on a vast portfolio of digital, optical, fine chemical and thin film coating technologies. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com.
